Due to a combination of a falling share price and several years of EPS growth, CLS's stock has de-rated form close to 50x to high-20 times P/E multiple (mid-20x if R&D expense is normalised).
That, combined with EPS growing in the high-teens means the multi-year under-performance of the stock has finally run its course, I think.
It's Hammer Time.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$262.39 |
Change
-1.560(0.59%) |
Mkt cap ! $127.2B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $264.45 | $259.33 | $60.61M | 231.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29 | $262.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $262.43 | 12 | 4 |
View Market Depth
| Last trade - 11.20am 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |